Subarachnoid hemorrhage screening
|
Subarachnoid Hemorrhage Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (2012)
|
|
Case Studies |
|
Subarachnoid hemorrhage screening On the Web |
|
American Roentgen Ray Society Images of Subarachnoid hemorrhage screening |
|
Risk calculators and risk factors for Subarachnoid hemorrhage screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Screening
Relatives screening
The risk of having subarachnoid hemorrhage (SAH) is much higher in patient with subarachnoid hemorrhage (SAH) in their first degree relatives compare to the general population and aneurysms tend to rupture at a smaller size and younger age than sporadic aneurysms.[1][2] This risk of aneurysm is also influenced by other risk factors such as cigarette smoking and hypertension.[3] The mode of inheritance can be variable, with autosomal dominant, recessive, and multifactorial transmission.
- First-degree relatives screening is recommend in individuals with a positive family history of subarachniid hemorrhage or cerebral aneurysm in more than two family members.[4]
- Screening is not recommend in individuals with only one affected first-degree relative.[5]
Heritable conditions
- Screening is recommend in the patient with heritable conditions such as:[6][7][8]
- Autosomal dominant polycystic kidney disease (ADPKD)
- Glucocorticoid remediable hyperaldosteronism (GRA)
- Connective tissue diseases
- Ehlers-Danlos syndrome IV
- Pseudoxanthoma elasticum
References
- ↑ Ronkainen A, Hernesniemi J, Puranen M, Niemitukia L, Vanninen R, Ryynänen M; et al. (1997). "Familial intracranial aneurysms". Lancet. 349 (9049): 380–4. doi:10.1016/S0140-6736(97)80009-8. PMID 9033463.
- ↑ Raaymakers TW (1999). "Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group. Magnetic Resonance Angiography in Relatives of patients with Subarachnoid hemorrhage". Neurology. 53 (5): 982–8. PMID 10496256.
- ↑ Rasing I, Nieuwkamp DJ, Algra A, Rinkel GJ (2012). "Additional risk of hypertension and smoking for aneurysms in people with a family history of subarachnoid haemorrhage". J Neurol Neurosurg Psychiatry. 83 (5): 541–2. doi:10.1136/jnnp-2011-301147. PMID 22423116.
- ↑ Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC, Brott T; et al. (2000). "Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council of the American Heart Association". Circulation. 102 (18): 2300–8. PMID 11056108.
- ↑ Schievink WI (1997). "Intracranial aneurysms". N Engl J Med. 336 (1): 28–40. doi:10.1056/NEJM199701023360106. PMID 8970938.
- ↑ Pepin M, Schwarze U, Superti-Furga A, Byers PH (2000). "Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type". N Engl J Med. 342 (10): 673–80. doi:10.1056/NEJM200003093421001. PMID 10706896.
- ↑ Chauveau D, Pirson Y, Verellen-Dumoulin C, Macnicol A, Gonzalo A, Grünfeld JP (1994). "Intracranial aneurysms in autosomal dominant polycystic kidney disease". Kidney Int. 45 (4): 1140–6. PMID 8007584.
- ↑ Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG (1998). "Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism". Hypertension. 31 (1 Pt 2): 445–50. PMID 9453343.